In addition to that the rescheduling of cannabis from Schedule I to III or IV should get the sector moving in a big way. That will open the doors wide for medical R&D, and new drug products hitting the market. Epidiolex won't be able to be prescribed unless they reschedule marijuana because it's made from the plant. They HAVE to reschedule it.